Dissociative amnesia is the inability to recall important autobiographical information, usually of a traumatic or stressful nature, that is too extensive to be explained by ordinary forgetting and not attributable to a substance, neurologic condition, or another mental disorder. It sits within the DSM-5-TR dissociative disorders chapter alongside dissociative identity disorder and depersonalization/derealization disorder, while ICD-11 places it in the dissociative disorders grouping (6B61) with a separate code for dissociative fugue. The clinical task is twofold: distinguish dissociative memory loss from neurologic amnesia, substance effects, and feigning, and then deliver phased, trauma-informed care while managing the high comorbid burden of posttraumatic stress disorder, depression, and suicidality. Most cases remit, but a meaningful minority become chronic, and acute presentations — particularly fugue with travel and identity confusion — demand a careful safety frame. Treatment evidence is limited to case series and expert consensus; pharmacotherapy targets comorbidity, not amnesia itself.

Population-level data on dissociative amnesia are sparse and methodologically heterogeneous, with prevalence estimates shaped by ascertainment setting and the screening instrument used. The disorder is uncommon in community samples but appears with meaningfully higher frequency in trauma-exposed and inpatient populations.

Prevalence

• Lifetime prevalence of dissociative amnesia in a longitudinal U.S. community cohort was approximately 1.0%, with women endorsing symptoms more often than men.¹
• Lifetime prevalence in international community samples ranges from roughly 1.0% to 7.3% depending on instrument and threshold, with the higher figures driven by structured interviews that capture localized and selective amnesia.²
• Rates rise sharply in psychiatric inpatient samples (point prevalence 7-8%) and in populations exposed to combat, intimate partner violence, or childhood maltreatment.^2-3

Demographics

• Onset can occur at any age, but most cases present in adolescence or early adulthood, often in temporal proximity to an identifiable stressor.³
• Female-to-male ratio is approximately 2:1 in clinical samples, paralleling the sex distribution of PTSD.^1,3
• Dissociative fugue, the rarer subtype, has historically been described in adults exposed to war, disaster, or severe personal crisis.³

Comorbidity and risk factors

• PTSD is the most common comorbidity, present in a majority of clinical cases; major depressive disorder, anxiety disorders, and somatic symptom disorder are also frequent.^3-4
• Suicide attempts and non-suicidal self-injury are markedly elevated, with one inpatient series reporting prior attempts in over 70% of patients with dissociative disorders.⁴
• Childhood physical and sexual abuse, neglect, early loss, and exposure to combat or interpersonal violence are the most consistently replicated antecedents.^3,5

Dissociative amnesia is best understood as a stress-related disruption of autobiographical memory retrieval rather than a primary storage failure. Current models integrate neurocircuit findings with trauma-developmental risk to explain why episodic content becomes inaccessible while semantic and procedural memory remain largely intact.

Neurocircuit and imaging findings

• Functional imaging during dissociative amnesia and depersonalization states shows increased prefrontal (medial and ventrolateral PFC) activity with concurrent suppression of limbic structures, particularly the amygdala and hippocampus.^6-7
• This pattern is the inverse of the limbic hyperactivation typically seen in PTSD intrusion states and supports the corticolimbic inhibition model of dissociation.⁶
• Case studies of dissociative amnesia have reported reduced hippocampal activation during autobiographical memory retrieval that normalizes with recovery.⁷
• Reductions in hippocampal and amygdalar volume have been described across dissociative disorders, though findings overlap with PTSD and are not specific.^6-7

Genetics and developmental risk

• Twin studies of dissociative experiences estimate genetic contributions of roughly 45% to 55%, with the remainder reflecting shared and non-shared environmental influences.⁸
• No replicated GWAS findings exist for dissociative amnesia specifically; candidate-gene work has examined serotonergic and HPA-axis stress-response variants shared with PTSD, with inconsistent replication.^8,13
• Early and repeated interpersonal trauma, disorganized attachment, and neglect are the most robust developmental risk factors.^3,5

Integrative model

• The prevailing model frames dissociative amnesia as a defensive over-engagement of prefrontal inhibitory control over limbic memory retrieval, triggered by overwhelming affect linked to traumatic material.^6,9
• Memory is typically retained at encoding but rendered inaccessible to voluntary, conscious retrieval; implicit and state-dependent recall may still influence behavior and affect.⁹

DSM-5-TR defines dissociative amnesia by an inability to recall important autobiographical information, typically of a traumatic or stressful nature, that exceeds ordinary forgetfulness and causes clinically significant distress or impairment.¹⁰ The exclusion criteria carry the diagnostic weight: the deficit cannot be better explained by another mental disorder, a substance, or a medical or neurologic condition.

DSM-5-TR core criteria

• Criterion A: inability to recall important autobiographical information, usually of a traumatic or stressful nature, inconsistent with ordinary forgetting.¹⁰
• Criterion B: clinically significant distress or impairment in social, occupational, or other important areas of functioning.¹⁰
• Criterion C: not attributable to the physiologic effects of a substance (including alcohol blackout) or a neurologic or other medical condition such as traumatic brain injury, complex partial seizures, or amnestic disorder.¹⁰
• Criterion D: not better explained by dissociative identity disorder, PTSD, acute stress disorder, somatic symptom disorder, or major or mild neurocognitive disorder.¹⁰

Specifier — with dissociative fugue

• Apparently purposeful travel or bewildered wandering associated with amnesia for identity or other important autobiographical information.¹⁰
• The fugue specifier is retained in DSM-5-TR rather than coded as a separate disorder, reflecting evidence that fugue is a presentation of dissociative amnesia rather than a distinct entity.^10-11

Patterns of amnesia (clinical descriptors, not separate diagnoses):

• Localized: inability to recall events during a circumscribed period, typically hours to days surrounding a traumatic event.¹⁰
• Selective: ability to recall some but not all events during a circumscribed period.¹⁰
• Generalized: complete loss of memory for one's life history, including identity; rare and often associated with severe trauma.¹⁰
• Systematized: loss of memory for a specific category of information (a particular person, a family event).¹⁰
• Continuous: inability to recall events from a specific time forward, including ongoing experiences.¹⁰

ICD-11 considerations

• ICD-11 codes dissociative amnesia as 6B61 within the dissociative disorders grouping and assigns dissociative fugue its own code (6B61.0) as a subtype rather than a specifier.¹¹
• ICD-11 requires that the amnesia not be due to substance use, medication, or another medical or mental disorder, paralleling the DSM-5-TR exclusions.¹¹

The cardinal feature is a gap in autobiographical recall that the patient often cannot fully describe, sometimes accompanied by indifference to the deficit (la belle indifférence) or, conversely, by marked distress. Onset is typically abrupt and tied to an identifiable stressor, though delayed presentations after a latent period are well described.^3,12

Typical presentation

• Sudden, circumscribed loss of memory for a stressful event or period, with intact orientation, attention, and general cognition.^3,12
• Procedural memory, language, and semantic knowledge are preserved; the patient can usually drive, dress, and converse normally.¹²
• Anterograde memory is intact; new learning continues during the amnestic episode, distinguishing it from neurologic amnestic syndromes.^12-13

Dissociative fugue

• Sudden, unexpected travel away from home or customary surroundings with inability to recall some or all of one's past.^10-11
• Confusion about personal identity or, less commonly, assumption of a partial or complete new identity.¹⁰
• Episodes range from hours to months; resolution is usually abrupt, with subsequent amnesia for the fugue period itself.^11-12

Associated features

• Depersonalization and derealization symptoms are common during and after episodes.¹²
• Patients frequently endorse alexithymia, somatic symptoms, and trance-like states.^12-13
• High rates of comorbid depression, PTSD, and suicidality require active screening at every visit.^3-4

Course and red flags

• Acute episodes often remit within days to weeks, particularly when the patient is removed from the precipitating stressor and offered a safe, structured environment.^3,12
• Chronic or recurrent amnesia, generalized amnesia, and amnesia accompanied by identity alteration suggest a more complex dissociative disorder and warrant specialist evaluation.^3,13

Because dissociative amnesia is defined by what it is not, the differential drives diagnostic confidence. The bedside priority is excluding treatable neurologic and metabolic causes; the secondary task is distinguishing it from other psychiatric entities and from feigning.

Neurologic and medical mimics

• Traumatic brain injury: post-traumatic amnesia is associated with loss of consciousness, anterograde deficits, and identifiable injury; neurologic exam and neuroimaging are essential.^13-14
• Transient global amnesia: abrupt anterograde amnesia lasting <24 hours, typically in adults over 50, with repetitive questioning and preserved identity; semantic and remote memory are intact.¹⁴
• Complex partial seizures and postictal states: stereotyped episodes, automatisms, and EEG abnormalities; consider in any patient with brief, recurrent amnestic episodes.^13-14
• Wernicke-Korsakoff syndrome: anterograde amnesia with confabulation and oculomotor signs in a thiamine-deficient patient.¹⁴
• Other: hypoglycemia, hypoxia, encephalitis (including autoimmune limbic encephalitis), stroke involving medial temporal or thalamic structures, and major or mild neurocognitive disorder.^13-14

Substance-related amnesia

• Alcohol blackout: anterograde amnesia during heavy intoxication, with intact behavior at the time and no recall afterward.¹⁴
• Benzodiazepine, GHB, ketamine, and anticholinergic intoxication can each produce anterograde amnesia confined to the period of intoxication.¹⁴

Other psychiatric disorders

• PTSD: amnesia for aspects of the trauma is itself a PTSD criterion; diagnose dissociative amnesia separately only when memory loss is the predominant feature or extends well beyond the traumatic event.¹⁰
• Dissociative identity disorder: recurrent amnesia is a criterion, but identity disruption with two or more distinct personality states is required.¹⁰
• Major or mild neurocognitive disorder: progressive, multidomain cognitive decline with objective deficits on testing.¹⁰
• Conversion (functional neurological symptom) disorder: motor or sensory symptoms inconsistent with neurologic disease, sometimes co-occurring with dissociative amnesia.¹⁰

Factitious disorder and malingering

• Feigned amnesia is suggested by external incentive (legal charges, compensation), inconsistent performance on memory testing, and amnesia that conveniently spans the period of alleged wrongdoing.¹⁵
• Forced-choice symptom validity tests (e.g., Test of Memory Malingering, Word Memory Test) show below-chance performance in feigning but typically normal performance in genuine dissociative amnesia.¹⁵

Assessment proceeds in parallel along two tracks: a careful psychiatric interview that documents the pattern and content of the amnesia, and a medical workup sufficient to exclude neurologic and metabolic causes. The first interview should also screen aggressively for suicide risk and trauma sequelae.^3-4

History elements

• Detailed timeline of the amnestic episode: onset, duration, content lost, and any retained fragments.¹²
• Precipitating stressors, trauma history (including childhood maltreatment and interpersonal violence), and prior dissociative episodes.^3,12
• Substance use, medication review (benzodiazepines, anticholinergics, sedating agents), and head injury history.¹⁴
• Family history of dissociative, mood, anxiety, and psychotic disorders.³
• Collateral history from family, employers, or law enforcement is often essential, particularly in fugue.¹²

Mental status and physical exam

• Full mental status examination, with explicit testing of orientation, attention, anterograde memory, and remote semantic knowledge.¹²
• Neurologic exam focused on cranial nerves, gait, coordination, and signs of head injury or focal deficit.¹⁴
• Vital signs and general examination for signs of trauma, intoxication, or systemic illness.¹⁴

Validated instruments

• Dissociative Experiences Scale (DES-II): 28-item self-report; scores >30 suggest a high-dissociation group warranting structured follow-up.¹⁶
• Structured Clinical Interview for DSM-5 Dissociative Disorders (SCID-D): the reference standard structured interview for dissociative disorders.¹⁷
• Multiscale Dissociation Inventory and Somatoform Dissociation Questionnaire (SDQ-20) provide complementary symptom mapping.¹⁶
• For PTSD comorbidity, the Clinician-Administered PTSD Scale (CAPS-5) or PCL-5 is recommended.¹⁸

Laboratory and imaging

• Baseline workup for new amnesia includes CBC, comprehensive metabolic panel, TSH, B12, glucose, and a urine toxicology screen.¹⁴
• Neuroimaging (CT or preferably MRI) is indicated when onset is acute, neurologic signs are present, or the pattern suggests a structural cause.¹⁴
• EEG is indicated when episodes are brief, stereotyped, or accompanied by automatisms.¹⁴
• Symptom validity testing is appropriate when feigning is suspected and should be administered by a trained neuropsychologist.¹⁵

What not to order

• Routine "truth serum" interviews with amobarbital or benzodiazepines are not supported and carry legal and therapeutic risks.^12,19
• Hypnotically retrieved memories are not admissible in many jurisdictions and may produce confabulated content; their use for memory recovery is discouraged.^12,19

No randomized controlled trial has established a first-line treatment specifically for dissociative amnesia; the evidence base is composed of case series, expert consensus, and extrapolation from PTSD and complex trauma literature.^19-20 The pragmatic frame is phased, trauma-informed psychotherapy with pharmacotherapy reserved for comorbid disorders.

General principles

• Establish safety first: address suicide risk, ongoing trauma exposure, and substance use before attempting memory work.^19-20
• Avoid pressured memory retrieval; spontaneous return of memory is common and forced recovery risks retraumatization and confabulation.¹⁹
• Treat comorbid PTSD, depression, and anxiety on their own terms.^19-20

Psychotherapy

• Phase-oriented trauma treatment (stabilization, trauma processing, integration) is the dominant clinical framework and is endorsed by the International Society for the Study of Trauma and Dissociation expert consensus guidelines.¹⁹
• Limited evidence suggests cognitive behavioral therapy for trauma, prolonged exposure, and EMDR can be effective when stabilization is adequate, though dissociative amnesia is often excluded from PTSD RCTs.^20-21
• Some experts recommend grounding techniques, paced exposure, and explicit dissociation-management skills before any trauma-focused work, though high-quality evidence is lacking.¹⁹

Pharmacotherapy

• No medication has FDA approval for dissociative amnesia and no agent reliably restores memory.^19-20
• SSRIs and SNRIs are reasonable first-line agents for comorbid PTSD or depression; sertraline and paroxetine are FDA-approved for PTSD.^18,20
• Prazosin may be useful for trauma-related nightmares; evidence in PTSD is mixed but supports a trial when nightmares are prominent.¹⁸
• Benzodiazepines should generally be avoided: they can worsen dissociation, impair fear extinction in PTSD, and create dependence.^18,20
• Limited case-series evidence supports cautious use of low-dose atypical antipsychotics or naltrexone for severe dissociative symptoms; certainty is very low.²⁰

Neuromodulation

• No established role for ECT, rTMS, or other neuromodulation in dissociative amnesia itself; consider only for treatment-resistant comorbid mood disorders by standard indications.^13,20

Adjunctive

• Family and systems work to reduce ongoing stressors and rebuild support.¹⁹
• Occupational and functional rehabilitation, particularly after prolonged or fugue episodes.¹⁹
• Coordinated care with social services, legal aid, and victim-advocacy resources when intimate partner violence or trafficking is identified.¹⁹

The principal harms in this condition come from two directions: iatrogenic destabilization from poorly timed trauma work or memory-recovery techniques, and missed neurologic diagnoses when the workup is truncated. The evidence base for treatment is thin and disproportionately drawn from case series and tertiary specialty centers.^19-20

Treatment-related harms

• Premature, unstabilized trauma processing can precipitate suicidality, severe dissociation, and disengagement from care.¹⁹
• Hypnotically or sedative-assisted memory retrieval risks confabulated memories with legal and interpersonal consequences.^12,19
• SSRIs and SNRIs carry standard class effects (GI upset, sexual dysfunction, activation, hyponatremia, withdrawal syndrome on discontinuation).¹⁸
• Benzodiazepines may worsen dissociation and impede PTSD recovery; long-term use risks tolerance, dependence, and falls in older patients.^18,20

Diagnostic harms

• Anchoring on a psychiatric diagnosis can delay identification of TBI, autoimmune limbic encephalitis, seizure disorders, or substance-related amnesia.^13-14
• Conversely, over-attribution of new neurologic deficits to dissociation in a known patient can miss intercurrent medical illness.¹⁴

Evidence-base limitations

• No RCTs specifically address dissociative amnesia; treatment recommendations derive largely from expert consensus and PTSD literature.^19-20
• Available studies are limited by small samples, selection bias toward tertiary care, and lack of standardized outcome measures.^19-20
• Publication bias likely overstates response to high-profile interventions (hypnosis, sedative interviewing) reported in older case literature.¹⁹
• Cross-cultural validity of Western dissociation instruments is incompletely characterized.¹⁶

Demographic and contextual factors shape both presentation and treatment planning. Trauma context — childhood maltreatment, combat, intimate partner violence, displacement — is usually more clinically informative than age alone.^3,5

Pediatric

• Children may present with apparent memory gaps for abusive episodes, school failure, or daydreaming states; developmental considerations limit the use of adult dissociation scales.²²
• Differential includes inattentive ADHD, absence seizures, and developmental amnesia syndromes; child protective evaluation is mandatory when maltreatment is suspected.²²

Geriatric

• New amnesia in older adults is far more often neurodegenerative or vascular than dissociative; pursue cognitive testing and neuroimaging before assigning a dissociative diagnosis.¹⁴
• Delirium and medication effects (especially anticholinergics and benzodiazepines) should be ruled out.¹⁴

Perinatal

• Postpartum presentations can include fugue-like states and amnesia in the context of severe psychosocial stress, intimate partner violence, or unrecognized postpartum psychosis, which itself is a psychiatric emergency.²³
• SSRI selection should account for lactation safety; sertraline is generally preferred.¹⁸

Comorbid medical illness

• Patients with epilepsy, multiple sclerosis, or autoimmune limbic encephalitis can develop genuine dissociative amnesia layered onto organic memory disturbance; coordinated neurology-psychiatry care is essential.^13-14

Comorbid substance use

• Substance use can both mimic and complicate dissociative amnesia; comprehensive treatment must address use disorders directly.²⁰

Cultural considerations

• Trance and possession states are part of normative religious and cultural practice in many populations and should not be pathologized; DSM-5-TR and ICD-11 both require distress or impairment for a diagnosis.^10-11
• Conceptualization of memory, trauma, and self varies across cultures and shapes both symptom presentation and treatment engagement; the DSM-5-TR Cultural Formulation Interview is a structured tool for this evaluation.^10,24

Most acute dissociative amnesia episodes remit, often within days to weeks, particularly when the patient is safe and supported.^3,12 A meaningful minority follows a chronic, relapsing course, especially when childhood trauma, ongoing stressors, or comorbid PTSD and DID are present.

Course patterns

• Acute, single-episode amnesia following an identifiable stressor typically resolves with stabilization and return to a safe environment.^3,12
• Chronic and recurrent amnesia is more common when there is repeated trauma exposure, complex PTSD, or DID features.^3,13
• Generalized amnesia for personal identity carries a more variable prognosis and often warrants specialist referral.^3,13

Outcome considerations

• Functional outcome is closely tied to comorbid PTSD severity and to social and occupational support.^3-4
• Suicide risk persists across the course of the disorder and should be reassessed at every visit.⁴
• Mortality data specific to dissociative amnesia are limited; the available literature implicates suicide and accidents or victimization during fugue states as the principal contributors.^4,13

Acute presentations — particularly fugue, generalized amnesia, and amnesia with prominent suicidality — require a structured safety frame before any therapeutic intervention. The first task in the ED is medical and substance-related rule-out.¹⁴

Hospitalization criteria

• Acute suicidality, severe self-harm, or inability to maintain safety in the community.⁴
• Dissociative fugue with disorientation, vulnerability to exploitation, or inability to identify safe shelter.¹²
• Suspected acute medical or neurologic etiology requiring inpatient workup.¹⁴

Acute management

• Provide a quiet, low-stimulation environment with consistent staff; avoid confrontational or coercive memory probing.^12,19
• Address pain, sleep, hydration, and basic medical stabilization first.¹⁴
• Engage trusted family or community contacts when identity is uncertain, with attention to the possibility that the precipitant is interpersonal violence within that network.¹²

Agitation management

• For severe agitation, follow standard protocols emphasizing verbal de-escalation; if pharmacologic management is required, prefer second-generation antipsychotics over benzodiazepines given the risk of worsening dissociation.^18,20

Safety-relevant comorbidity

• Active screening for ongoing intimate partner violence, trafficking, or coercive control is essential, particularly in fugue presentations.¹⁹
• Document trauma history with care and consideration of forensic implications; avoid leading interview techniques.¹⁹

Few corners of psychiatry are as contested as dissociative amnesia. Debate spans the validity of the construct, the reliability of recovered memories, and the boundary between trauma-induced amnesia and ordinary forgetting or feigning.^25-26

Construct validity

• A minority of memory researchers argue that true dissociative amnesia for trauma is rare or non-existent, citing evidence that traumatic events are usually well remembered and sometimes intrusively so.^25-26
• Proponents of the diagnosis point to converging case series, neuroimaging findings, and prospective studies of childhood abuse survivors showing failures of recall.^6,27

Recovered memories

• The 1990s "memory wars" highlighted the risk of suggestion-induced false memories during therapy, leading to widespread caution about memory-recovery techniques.²⁶
• Current expert consensus is that spontaneous return of memory is well documented, while therapeutically induced retrieval is unreliable and ethically fraught.^19,26

Diagnostic boundaries

• The boundary between PTSD with dissociative amnesia, dissociative amnesia as a primary diagnosis, and DID is fuzzy and clinician-dependent.^10,13
• Some authors propose collapsing dissociative amnesia and the dissociative subtype of PTSD into a single trauma-spectrum framework, though DSM-5-TR and ICD-11 retain them as separate.²⁵

Forensic uncertainty

• Claims of amnesia for violent acts, particularly homicide, are common (20-40% of perpetrators in some series) and may reflect a mix of genuine dissociation, intoxication, and feigning.¹⁵
• Symptom validity testing improves but does not resolve the differentiation.¹⁵

Cross-cultural and historical variation

• Reported prevalence of dissociative amnesia and fugue has varied widely across decades and cultures, raising questions about diagnostic fashion versus true epidemiologic change.²⁵

• Dissociative amnesia is defined by inability to recall important autobiographical information, usually traumatic or stressful, that exceeds ordinary forgetting and is not attributable to substances, medical conditions, or another mental disorder.¹⁰
• Localized amnesia is the most common pattern; generalized amnesia with loss of personal identity is rare and often associated with severe trauma.¹⁰
• Dissociative fugue is now a specifier of dissociative amnesia in DSM-5-TR, not a separate disorder; ICD-11 retains it as a coded subtype (6B61.0).^10-11
• Anterograde memory and the ability to learn new information are preserved in dissociative amnesia, distinguishing it from neurologic amnestic syndromes.^12-13
• Transient global amnesia is anterograde, lasts under 24 hours, and typically affects adults over 50; it is not dissociative amnesia.¹⁴
• The DES-II is a screening instrument; the SCID-D is the structured interview reference standard for dissociative disorders.^16-17
• No medication is FDA-approved for dissociative amnesia; SSRIs and SNRIs treat comorbid PTSD and depression.^18,20
• Sertraline and paroxetine are FDA-approved for PTSD; prazosin can reduce trauma-related nightmares.¹⁸
• Benzodiazepines should generally be avoided in dissociative amnesia and PTSD because they worsen dissociation and impair fear extinction.^18,20
• Phase-oriented trauma therapy (stabilization, processing, integration) is the dominant clinical framework despite the lack of RCTs.¹⁹
• Hypnosis and sedative-assisted interviewing for memory retrieval are not recommended due to confabulation risk and forensic inadmissibility.^12,19
• Comorbid PTSD, depression, and suicidality are highly prevalent; suicide screening at every visit is standard.^3-4
• Imaging studies show increased prefrontal activity with reduced amygdalar and hippocampal activation during dissociative states.^6-7
• Twin studies estimate genetic contributions to dissociative experiences at roughly 45% to 55%, with substantial environmental contribution.⁸
• Most acute dissociative amnesia episodes remit within days to weeks; chronic or recurrent cases warrant evaluation for DID or complex PTSD.^3,12

No external funding. No conflicts of interest declared. Peer-review status: pending.